Parasites 1 Flashcards
Antiparasitic MoA Benzimidazoles
Binds to nematode tubulin and prevents microtubule formation, leading to cell death - Albendazole, Mebendazole
Antiparasitic MoA Pyrantel
Nicotinic acetylcholine receptor inhibitors bind to neuromuscular junction receptors causing spastic paralysis of worms
Antiparasitic MoA Ivermectin
Inhibition of glutamate-gated chloride channels - increasing chloride levels causing paralysis of worms
Antiparasitic MoA Praziquantel
Induce an influx of calcium into the worm leading to worm paralysis and worm death
Ascaris lumbricoides Epidemiology
Tropical, poor sanitation and warm weather. 25% of humans infected. Disproportionately affects impoverished children
Ascaris lumbricoides Pathogenesis
Early usually asymptomatic. Eosinophilic pneumonitis Loeffler’s syndrome - dry cough at 1-3 weeks, SOB, asthma-like syndrome associated with allergic response to larvae. Some people may cough up larvae. Intestinal infection commonly causes abdominal discomfort, rarely intestinal obstruction due to a bolus of worms stuck at the ileocaecal valve. Ectopic infection may rarely occur with ‘wandering worms’ - wandering is promoted by fever, anaesthetics, antihelminthic treatment etc
Ascaris lumbricoides Diagnosis
Eggs in stool, occasionally large worm. Adult worms may be detected by colonoscopy, barium meal or ultrasound
Ascaris lumbricoides Treatment
Albendazole, pyrantel
Ascaris lumbricoides Prevention
Improve sanitation, hand hygiene, mass drug administration
Ascaris lumbricoides Summary
Egg: crenelated, adult worm: 20-35cm, large bowel, transmission soil to mouth, Clinical: asymptomatic, Loeffler’s, GI obstruction, cholangitis, peritonitis. Distinct features: lung migration. Eosinophilia only if in lungs. Treatment: Albendazole.
Capillaria philippinensis Epidemiology
Philippines and Thailand, also Taiwan, Japan
Capillaria philippinensis Pathogenesis
Adults in the mucosa and submucosa of upper small intestine -> severe inflammation -> sloughing of mucosa. Worms can multiply within the gut -> internal autoinfection and overwhelming number of worms. Protein-losing enteropathy, malabsorption, watery diarrhoea -> dehydration and wasting (mortality >35% in untreated patients)
Capillaria philippinensis Diagnosis
Symptoms relate to worm burden. Most commonly diarrhoea, abdominal pain, borborygmi, weight loss. Abdominal distension and oedema may develop. Eggs in stool (occasionally larvae in severe cases)
Capillaria philippinensis Treatment
Albendazole, prolonged treatment necessary as larvae buried in mucosa may be insusceptible
Chagas Epidemiology
WHO estimates 5-8mil people worldwide infected. Bolivia is peak, largely central and south America, including Mexico - Bolivia has the highest incidence and prevalence in the Americas, but there are parts of Bolivia where there is no transmission at all – there is no granularity of where the risk areas are – problem for countries, but also for migrant health services – difficult to ascertain lifetime risk and offer testing to everyone (probably the safest)
Chagas Vector
Triatomine bug - painless bite, bigger than mosquitos or midges
Chagas Organism
Trypanosoma cruzi
Chagas Sequelae
2/3 indeterminate - disease free, 1/3 determinate - disease - End organ damage to heart and GI tract (or both
Chagas Transmission
Vector faeces, vertical, transfusion, transplantation, oral ingestion (large dose - fatal)
Chagas Treatment
No evidence clearing the parasite has any impact on sequelae, BUT growing interest to treat women of childbearing age to interrupt vertical transmission
Chagas Atypical presentations
HIV mimic cerebral toxo with SOL/meningoencephalitis, transplant recipients - fever, rash, myocarditis (mimics acute Chagas)
Chagas Exposure
Risk related to duration of exposure to Triatomine, probably need to be living at least 6 months in area, no cases described in traveller
Chagas Life cycle
Bug gets infected from blood meal of infected host, replication occurs in the stomach. Bug bites to take a blood meal, satisfied with blood meal defaecates – causes itch and human scratch inoculates it. Portal of entry mucus membrane of eye – often bite around the eye, defaecates – wipe faeces into eye – Romanya’s sign (infrequent clinical sign) – looks like periorbital cellulitis – manifestation of acute Chagas
Chagas Family
Diagnosis should prompt wider family testing, may have common maternal source
Chagas Natural history
Self-cure does not occur in most infected individuals, paradigm is lifelong infection. Infection does not necessarily lead to disease. Indeterminate ‘have not developed end-organ disease’ – just have a positive antibody test. most determinate disease is isolated cardiac disease, some digestive (megacolon), some unlucky get both
Chagas Cardiac disease
Arrhythmia, Myocardial abnormalities esp DCM -> aneurysms -> thromboembolic events
Chagas GI disease
Megaoesophagus or Megacolon - severe constipation
Chagas Serology
2 tests to confirm, eg RDT screen, ELISA confirm. Titre unhelpful, Ab response to therapy variable
Chagas PCR
Not widely available, only performed if seropositive, helps to guide giving treatment, but killing parasite may not have any impact on whether they develop disease in the future, and the same for those with disease
Chagas Xenodiagnosis
Xenodiagnosis no longer routinely used – put the bug on the patient to bite (painlessly) to take a blood meal – then keep triatomine alive for a few weeks, then examine stomach for whether the parasite present – need to use the right triatomine for the person’s geographical location
Chagas Treatment
Benznidazole or nifurtimox, 60d poorly tolerated 1/3 will not complete - effective for parasite clearance, effect upon clinical endpoints unproven except prevents vertical transmission. BENEFIT trial demonstrated no benefit in reducing progression of cardiac disease
Chagas Treatment who
Indeterminate (pre-disease) seropositive, and immunocompromised with determinate, plus girls and women of child-bearing age, in addition to infants and children - treatment is toxic, lengthy and of variable benefit, but patients often want it as don’t like the idea of parasite
Chagas Treatment future
BENDITA study - shorter courses of benznidazole (2w instead of 60d) + MULTIBENZ study - probably can get away with shorter and lower dose courses
Chagas HTD protocol
Confirm serology, PCR, assess end-organ (cardiac ECG, 5d holter TTE, GI only if sx), explain diagnosis and implications for patient, siblings, children (if female), discuss merits and uncertainties of antiparasitic treatment, treat the underlying end-organ disease, and offer antiparasitic treatment, annual review to follow progression to determinate disease
Chagas Summary
2/3 infections ‘silent’, serodiagnosis then PCR, benznidazole treatment is toxic, therapeutic benefit uncertain - affects parasitological cure but impacts upon future end-organ damage less clear, shorter, better tolerated regimens are shifting balance towards offering treatment to wider range of patients
Chagas Vector control
Spraying campaigns, vector avoidance
Chagas Vertical transmission
Vertical transmission occurs in 5% pregnancies in women with T cruzi infection, without testing the transmission is invisible, antiparasitic treatment of infants is highly effective so early detection and treatment is critical, antiparasitic treatment during pregnancy is contraindicated, but future pregnancies can be protected by treatment, pre-conception antiparasitic treatment prevents almost all vertical transmission
Chagas UK Chagas Hub
Diagnosis gap in London, community engagement to promote diagnosis and engagement in care successful
Chagas Epidemiology
Most important parasitic disease of the Americas, 6-7million infected, 100 million at risk of infection, 25% of Latin America
Chagas Romana’s sign
Parasite enters through eye and looks like periorbital cellulitis
Chagas Pathogenesis
Not well understood, three theories: direct presence of parasite, neuropathy (destruction of ganglionic nerve fibres), autoimmune response - T cruzi Ag elicits a powerful autoimmune response. An efficient immune response can control the infection, leading to an indeterminate form of the disease, while a deficient response can result in chronic complications. Chronic chagas heart disease involves a persistent low-grade immune mediated myocardial injury and parasite-dependent myocardial damage
Chagas Diagnosis acute phase
Blood films/buffy coat/wet prep looking for T cruzi trypomastigotes - parasitaemia may not be detectable -> qPCR
Chagas Diagnosis chronic phase
Serology is gold standard to detect parasite-specific IgG - screen with commercial ELISA confirm positive with in-house IFAT. WHO recommend using 2 different serological assays to confirm T cruzi infection. qPCR to determine if parasitaemia detectable - parasitaemia in pregnant woman increases risk of congenital infection, reactivation in immunosuppressed people, and can be used to monitor response to treatment
Chagas Treatment
Benznidazole or Nifurtimox for 60-90d, treatment women of reproductive age before pregnancy can effectively prevent congenital transmission. Post-partum treatment is also an option
Chagas Control initiatives
Interrupt transfusion transmission through blood donor screening, interrupt vector through residual insecticide spraying - huge endeavour, 100s of 1000s of properties have been upgraded/sprayed - huge infrastructure to do this, cannot ignore zoonosis - it will come back, cannot be eradicated. Limited prospects for vaccine development - intracellular
Cryptosporidium Clinical
Watery diarrhoea, can vary from asymptomatic to life-threatening, 2-4w in immunocompetent, chronic in immunosuppressed, infection does not provide immunity to further infection. Contributes to childhood malnutrition, growth impairment and cognitive deficit
Cryptosporidium Transmission
Faecal oral contaminated foods, aerosolised droplets, note infected children shed oocysts for up to a month after diarrhoea resolved, waterborne outbreaks, chlorine has little effect, water needs to be filtered, small infectious dose (100 oocysts), animal reservoirs
Cryptosporidium Epidemiology
Globally caused 133,000 deaths and loss of 820,000 DALYs
Cryptosporidium Treatment
Mostly self-limited. Paromomycin, nitazoxanide in immunocompetent effective, but not in immunosuppressed - healthy host immune system is essential to effectiveness of nitazoxanide
Cutaneous myiasis Tumbu
C anthropophaga - Botfly D hominis
Cyclospora catetanensis Clinical
Acute self-limiting diarrhoea or asymptomatic, can be more prolonged in immunosuppressed
Cyclospora catetanensis Treatment
SXT
Cystoisospora belli Clinical
Self-limited watery diarrhoea, more prolonged in immunocompromised
Cystoisospora belli Treatment
SXT
Enterobius vermicularis Epidemiology
Cosmopolitan - high and low income countries. Is not soil transmitted (eggs do not need contact with soil to embryonate). Broadest geographic range of any helminth. Commonly found in school-aged children.
Enterobius vermicularis Treatment
Albendazole, Mebendazole, Pyrantel. Repeat treatment after 2-4 weeks is indicated as the eggs survive several weeks in environment and reinfection is frequent. The whole family should be treated, and bed linen/clothes etc should be washed
Enterobius vermicularis Summary
Egg flat on one side. Adult worm 1-2mm in rectum. Transmission faecal-oral. Clinical: asymptomatic, pruritus, vaginal discharge. Distinct feature: family clusters, sellotape test. Eosinophilia unusual. Treatment Albendazole
Free-living amoeba N fowleri reservoir
Warm stagnant water - exists as trophozoite, flagellate, double-walled cyst, including swimming pools
Free-living amoeba Acanthamoeba reservoir
Water salt or fresh, including chlorinated, in addition to soil and air (droplet particles)
Free-living amoeba Balamuthia mandrillaris reservoir
Soil
Free-living amoeba PAM Pathogenesis
N fowleri enter nasal sinuses, migrates along olfactory nerve, incubation 2-5d severe headache, meningism -> coma
Free-living amoeba PAM Diagnosis
Direct exam of CSF (Naegleria, Balamuthia not Acanthamoeba), PCR
Free-living amoeba PAM Treatment
Amphotericin B, Miltefosine, Nitroxoline (none work well, 97% mortality)